Scientific Advisory Board
| Copyright 2006 - 2008 Abiant, Inc. |
 | |  | |  | |  |
About Us
Advanced BioImaging to Accelerate New Therapeutics
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
Joseph Mantil, M.D., Ph.D., Advisor in Medical Imaging and Clinical Studies
Dr. Mantil has been Director of the Kettering Medical Center Department of Nuclear Medicine and PET
since 1986, and is Clinical Professor of Medicine and Chief of the Division of Nuclear Medicine at
Wright State University School of Medicine. He has served as the Principal investigator for numerous
PET imaging research studies focused on the central nervous system, oncology, and cardiology.
These studies have involved a spectrum of radiotracers incorporating radioisotopes of carbon,
fluorine, oxygen, nitrogen, and other chemistries. Dr. Mantil is board certified in internal medicine and
nuclear medicine.
since 1986, and is Clinical Professor of Medicine and Chief of the Division of Nuclear Medicine at
Wright State University School of Medicine. He has served as the Principal investigator for numerous
PET imaging research studies focused on the central nervous system, oncology, and cardiology.
These studies have involved a spectrum of radiotracers incorporating radioisotopes of carbon,
fluorine, oxygen, nitrogen, and other chemistries. Dr. Mantil is board certified in internal medicine and
nuclear medicine.
Wallace Mendelson, M.D., Advisor in Sleep Disorders and Anxiety
Dr. Mendelson has extensive experience in the pharmacology and clinical application of therapeutics
for sleep disorders. He is Professor of Psychiatry and Clinical Pharmacology (ret.) at the University of
Chicago, a consultant to pharmaceutical companies, and a member of the editorial board of the
Internal Journal of Sleep and Wakefulness. Dr. Mendelson was previously Director of the Sleep
Research Laboratory at the University of Chicago, Chief of the Section on Sleep Studies at the
National Institute of Mental Health, Director of the Sleep Laboratory at the Cleveland Clinic, and former
President of the Sleep Research Society.
for sleep disorders. He is Professor of Psychiatry and Clinical Pharmacology (ret.) at the University of
Chicago, a consultant to pharmaceutical companies, and a member of the editorial board of the
Internal Journal of Sleep and Wakefulness. Dr. Mendelson was previously Director of the Sleep
Research Laboratory at the University of Chicago, Chief of the Section on Sleep Studies at the
National Institute of Mental Health, Director of the Sleep Laboratory at the Cleveland Clinic, and former
President of the Sleep Research Society.
Dr. Mosconi is Assistant Professor in the Department of Psychiatry at New York University. Her
research interests include PET and MRI imaging in the early diagnosis of Alzheimer’s Disease. She
has developed novel approaches to automatically and reliably sample brain regions of interest on
PET scans in patients with highly varying degrees of atrophy. She has also demonstrated the very
early prediction of dementia and the accurate classification of dementia types using PET imaging.
Her work includes the diagnostic application of MRI and CSF markers, and translation of image
sampling and analysis methods to preclinical (animal) models of Alzheimer’s Disease. Dr. Mosconi
holds a Ph.D. degree in Neuroscience and Nuclear Medicine from the University of Florence, Italy, in
association with New York University School of Medicine.
research interests include PET and MRI imaging in the early diagnosis of Alzheimer’s Disease. She
has developed novel approaches to automatically and reliably sample brain regions of interest on
PET scans in patients with highly varying degrees of atrophy. She has also demonstrated the very
early prediction of dementia and the accurate classification of dementia types using PET imaging.
Her work includes the diagnostic application of MRI and CSF markers, and translation of image
sampling and analysis methods to preclinical (animal) models of Alzheimer’s Disease. Dr. Mosconi
holds a Ph.D. degree in Neuroscience and Nuclear Medicine from the University of Florence, Italy, in
association with New York University School of Medicine.
Lisa Mosconi, Ph.D., Advisor in Image Analysis and Dementias
Masanori Ichise, M.D., Ph.D., FRCPC, Advisor, PET Data Modeling and Analysis
Dr. Ichise is Medical Director of the Morton A. Kreitchman PET Center, Professor of Clinical Radiology
at Columbia University College of Physicians and Surgeons, and Co-director of the Division of
Nuclear Medicine. An internationally recognized researcher in PET and SPECT imaging of patients
with neuropsychiatric disorders such as Alzheimer’s and Parkinson’s diseases, he is well known for
his expertise in the quantification of imaging results. He has authored numerous articles and
pioneered multiple techniques for PET/SPECT analysis of brain chemistry. Before coming to
Columbia, he was Director of the Brain Molecular Imaging Program at Brigham and Women’s
Hospital in Boston and conducted research at Harvard Medical School. Previously, he was a
molecular imaging principal investigator at the NIH.
at Columbia University College of Physicians and Surgeons, and Co-director of the Division of
Nuclear Medicine. An internationally recognized researcher in PET and SPECT imaging of patients
with neuropsychiatric disorders such as Alzheimer’s and Parkinson’s diseases, he is well known for
his expertise in the quantification of imaging results. He has authored numerous articles and
pioneered multiple techniques for PET/SPECT analysis of brain chemistry. Before coming to
Columbia, he was Director of the Brain Molecular Imaging Program at Brigham and Women’s
Hospital in Boston and conducted research at Harvard Medical School. Previously, he was a
molecular imaging principal investigator at the NIH.